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Barrier sites such as the gastrointestinal tract are in constant contact with the environ-
ment, which contains both beneficial and harmful components. The immune system at
the epithelia must make the distinction between these components to balance tolerance,
protection, and immunopathology. This is achieved via multifaceted immune recognition,
highly organized lymphoid structures, and the interaction of many types of immune cells.
The adaptive immune response in the gut is orchestrated by CD4+ helperT (Th) cells, which
are integral to gut immunity. In recent years, it has become apparent that the functional
identity of these Th cells is not as fixed as initially thought. Plasticity in differentiated T cell
subsets has now been firmly established, in both health and disease.The gut, in particular,
utilizes CD4+ T cell plasticity to mold CD4+ T cell phenotypes to maintain its finely poised
balance of tolerance and inflammation and to encourage biodiversity within the enteric
microbiome. In this review, we will discuss intestinal helperT cell plasticity and our current
understanding of its mechanisms, including our growing knowledge of an evolutionarily
ancient symbiosis between microbiota and malleable CD4+ T cell effectors.
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INTRODUCTION
The adult human gastrointestinal tract is the largest surface area
of the body that contacts with the environment, covering 200–
300 m2 (1). This intestinal surface is constantly exposed to a diverse
range of foreign antigens originating from microorganisms (both
commensals and pathogens) and food antigens from the diet (2).
Commensal microorganisms play an essential role in extracting
nutrients from food that are otherwise inaccessible to the host
[such as the metabolism of vitamin K by E. coli (3)], they are
required for the development of the host’s immune system and
for the prevention of colonization of the gastrointestinal tract
by pathogens. Mucosal pathogens, including viruses, fungi, par-
asites, and bacteria, can cause pathology either by local effects
after mucosal colonization – such as inducing local inflammation
or secreting toxins – or, through systemic infection after breeching
mucosa. Microorganism-derived antigens, food-derived antigens,
and airborne particles, can be potential immunogens. An inap-
propriate response to these immunogens at the mucosal surface
can be detrimental, leading to local or systemic pathology that
result in acute or chronic inflammation. Therefore, it is essential
that the myriad of antigens present at the intestinal surface is dealt
with appropriately to minimize potential danger and maximize
host benefit. This protection is achieved by a flexible, multi-
layered system of physical, and immunological barriers within the
gastrointestinal tract.
A central part of the complex host defense system is gut-
associated lymphoid tissue (GALT). GALT is a system of highly
organized immune structures strategically placed along the entire
gastrointestinal tract, containing specialized micro-environments
where gut-derived antigens are presented by professional antigen
presenting cells (APCs) to lymphocytes [reviewed recently in Ref.
(4)]. The broad antigenic sampling within the GALT facilitates
the interaction between rare antigen-specific B and T cells lead-
ing to the initiation of an appropriate adaptive immune response
(5). CD4+ T cells are critical players in the adaptive immune
response within the GALT. Naïve T cells egress from the thymus
as immature T cells with a broad range of T cell receptors (TCRs)
and can be activated in the periphery following encounter with
their specific antigen. T cell activation is initiated by ligation of
the TCR by peptide–MHC class II complex in conjunction with
co-stimulatory signals. During T cell priming, cytokine receptor
ligation can skew activated T cells into a particular effector cell
type (6). These cell types are commonly referred to lineages or
subsets, with each being identified by selected expression of char-
acteristic transcription factors and effector molecules (7). With
the exception of thymically derived regulatory T cells (Tregs)
[reviewed in Ref. (8)], thymic emigrants lack any predisposition
to make effector molecules associated with a particular CD4+ T
cell subset, and require signals in the periphery to skew their dif-
ferentiation into a particular cell subset. Present understanding of
T cell lineage commitment is dominated by single fate model, a
process whereby a naive T cell differentiates along a terminal fixed
expression program, in response to signals at the time of antigen
encounter. However, this view has needed revision in light of find-
ings from many groups, which together demonstrate that CD4+ T
cell subset fate is not a permanent attribute, but rather a flexible,
plastic, feature that can be modified to suit the requirements of the
immune system at a particular point in space and time. Thus, the
new paradigm of T cell differentiation encompasses the ability of
CD4+ T cells to change between expression programs traditionally
thought to be mutually exclusive terminal states of differentiation
(9). This feature has been reported in vivo in several experimental
systems, and intriguingly, is a prominent feature of CD4+ T cell
biology within the GALT.
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The detailed mechanisms underlying T cell plasticity within the
GALT remains to be defined, but several factors that facilitate its
occurrence have been proposed and can be divided into extrin-
sic and intrinsic pathways. In this review, we will summarize the
recent literature on CD4+ T cell plasticity in the gut, highlight
possible underlying mechanisms and discuss its potential benefits
for intestinal homeostasis and health.
CD4+ T CELL DIFFERENTIATION IN THE GALT
The GALT contains one of the largest lymphoid cell population
found anywhere in the body. GALT is distributed along the intesti-
nal tract and is separated from the luminal content, containing
about 100 trillion microorganisms (10) and many dietary prod-
ucts,by a single epithelial layer covered with an intricate network of
glycoproteins; the mucous layers. The GALT provides three func-
tions: provides antigenic samples from throughout the GI tract;
optimizes the opportunities for naïve lymphocytes to encounter
antigen, and finally supports the activated lymphocyte and its
initial differentiation. A network of highly organized lymphoid
structures comprise the GALT (Figure 1) – including mesenteric
lymph nodes (mLNs), Peyer’s patches (PPs), isolated lymphoid
follicles (ILFs), cryptopatches (CPs), and fat-associated lymphoid
tissues – as well as the loose connective tissue of the lamina propria
(LP). Despite the numerous types of GALT, the organization of
all GALT lymphoid tissues shares a basic cellular architecture that
facilitates the interaction of APCs with lymphocytes and their sub-
sequent activation and differentiation. However, the GALT tissues
differ from each other both in function and in the physical distance
to the intestinal lumen; CP and ILFs are located directly under-
neath the epithelial layer, PPs are further from the lumen and
most distant are mLNs and fat-associated lymphoid tissues. The
specialized functions of each the GALT tissues have been recently
reviewed in Ref. (4), and therefore will not be discussed in detail
in this review.
Naïve L-selectin-expressing CD4+ T cells migrate from the
blood through high endothelial venules (HEVs) to the PPs, CP,
ILFs, and mLNs. In these inductive sites of the adaptive immune
system, they encounter their cognate antigen presented by APCs
on MHC class II. Naïve T cells that did not encounter their cognate
antigen leave via efferent lymphatic vessels into the systemic cir-
culation to continue their search for their cognate antigen. In PPs,
CP, and ILFs, dendritic cells (DCs) receive antigens transported
from the mucosal surface by specialized epithelial cells overlying
these lymphoid structures, the microfold (M) cells, and Goblet
cells [reviewed in Ref. (4)]. mLNs receive antigens via afferent
lymphatics that are connected with the PPs, while fat-associated
lymphoid tissues obtain antigen by lymphatic drainage directly
from the intestine and from the peritoneal cavity (4).
After activation in the intestine CD4+ T cells proliferate,
shed L-selectin from their surface, increase surface expression of
gut-specific adhesion molecules and differentiate into an effector
T cell, of a particular subset. Antigen-experienced effector T cells
usually leave via efferent lymphatic vessels and home to effector
tissues such as the intestine after re-circulation in the blood, but
FIGURE 1 | Architecture of gut-associated lymphoid tissue.
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some remain in the lymphoid organs to perform their specialized
effector functions (11). Upon arriving in the intestine, effector T
cells are likely to re-encounter their specific antigen presented by
a diverse range of cells such as macrophages, B cells various types
of DCs, and stromal and epithelial cells. This second antigen-
specific interaction will trigger the T cells to execute their effector
function.
It is the nature of antigen presentation and the surrounding
micro-environment that largely seems to determine the outcome
of CD4+ T cell differentiation and the subsequent spectrum of
T cell identities leaving the lymphoid structures (6). The CD4+ T
cell subsets currently recognized are: T helper cells of type-1 (Th1),
Th2, Th9, Th17, Th22, Tregs, and follicular helper T cells (Tfh).
Each subset is characterized by the potential to produce a defined
set of mediators such as cytokines and chemokines, respond to
particular stimuli via the expression of selected cytokine and
chemokine receptors, largely driven by so called“master regulator”
transcription factors (summarized in Table 1).
CD4+ T CELL PLASTICITY
Plasticity of effector CD4+ T cells has been increasingly recognized
in recent years. Initially, there were single reports of observations
of particular subsets behaving “non-typically,” by the expression
of transcription factors, cytokines, or both, of another subset.
Together these various reports support a more nuanced view of Tfh
differentiation, in place of the monolithic view of distinct, non-
interchangeable lineages (12). T helper cells are able to acquire a
mixed phenotype or to switch entirely to the transcription and
cytokine profile of another lineage (Table 2). These hybrid cells
or ex-Th lineage cells may either directly differentiate from naïve
CD4+ T cells or arise during secondary immunological challenge.
Current data suggest that, within the gut, particular transitions
between CD4+ T helper cell subsets occur and are important for
maintaining gastrointestinal homeostasis, as outlined below.
Th1/Th2 CELL PLASTICITY
T helper cells of type-1 cells are an abundant effector population
in the gut responsible for protection against invading intracellular
bacteria and viruses (31). In contrast, Th2 cells are absent in the
intestine of laboratory mice and humans under healthy conditions
(31, 32); not surprising in view of their role in coordinating host
responses to helminths and the absence of these organisms in a
healthy intestinal flora (31). Identification of Th1 and Th2 as dis-
tinct cell types was the first, time where CD4+ T cell subsets were
divided on the basis of phenotypic differences in vitro (33). It is
therefore interesting that culture of T cells under mixed Th1 and
Th2 conditions results in a continuum of cytokine expression,
with some single positive IFNγ+ or IL-4+ and double positive
cells, correlating with expression levels of Tbet and GATA-3 (34),
the respective master transcription factors for the Th1 and Th2
subsets, demonstrating these cell fates are not a distinct as origi-
nally thought. Importantly, this finding is consistent with in vivo
observations; during infections with Heligmosomoides polygyrus,
a parasite that triggers a strong Th2 response, Th1/Th2 hybrid
cells were observed (13). In the intestine, mLNs and spleen, these
Th1/Th2 hybrid cells express simultaneously the Tbet and GATA-3
and not transcription factors of other subsets [retinoic acid (RA)
receptor-related orphan nuclear receptor (ROR)γt or Bcl-6]. In
addition, they express the Th1 cell-associated molecules CXCR3
and IFNγ concordantly with the Th2 cell-associated IL-33R, IL-4,
IL-13, and IL-5. Furthermore, Th2 cells in vivo can express Tbet
and IFNγupon infection with lymphocytic choriomeningitis virus
(LCMV), a potent Th1 skewing pathogen. These Th1/Th2 hybrid
cells represent a stable phenotype, where attempts at reprogram-
ing by stimulation under Th1 or Th2 polarizing conditions result
in quantitative changes of Th1/Th2 cytokine production with-
out fully extinguishing either. Upon transfer into wild-type mice,
around 20% of LCMV-specific Th1/Th2 cells maintained their
expression of GATA-3, IL-4, and IL-13 alongside Tbet and IFNγ
Table 1 | Effector CD4+ T cells in the gut.
Cell
type
Differentiation
signals
Transcription
factor (master
transcription factor)
Cell surface
and cytokine
markers
Location in
the gut under
homeostatic conditions
Function
in the gut
Th1 IL-12, IFNγ Tbet, STAT1, STAT4, and
Runx3
CXCR3, IFNγ mLN, PP, CP, ILF, and LP Responding to intracellular
pathogens and assisting with viral
infections
Th2 IL-4, IL-2 GATA-3, STAT6, and STAT5 IL-33R, IL-4, IL-13, and IL-5 Virtually absent Responding to helminths
Th9 TGFβ, IL-4 PU.1 IL-9 Exact location to be determined Involved in tumor immunology
Th17 IL-6, TGFβ, IL-1β, and
(IL-23, IL-21)
RORγt, AhR, STAT3, Batf,
Runx1, and RORα
CD161, IL-17A, IL-17F, and
GM-CSF
mLN, PP, CP, ILF, and LP Protect the host from infectious
assault at mucosal site
Th22 IL-6, IL-13, and TNFα AhR CCR4, CCR6, CCR10, and
IL-22
Exact location to be
determined
Wound repair and induction of
antimicrobials
Tfh IL-6, IL-21 Bcl-6, Ascl2 CXCR5, PD-1, and IL-21 PP, ILF? Induce IgA production by GC B
cells to maintain a healthy
microbiota
iTreg TGFβ, IL-2 Foxp3, STAT5 IL-10, TGFβ mLN, PP, CP, ILF, and LP Suppressor capacity, keep
homeostatic balance in gut
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Table 2 | CD4+ T cell plasticity in the gut.
Plasticity in
the intestine
Capacity Features of hybrid
cell/ex-Th lineage cell
Origin Developmental mechanism Function in the gut References
Th1/Th2 Th1/Th2 hybrid cells Tbet+ CXCR3+ IFNg+
GATA-3+ IL-33R+ IL-4+
IL-13+ IL-15+
Naïve T cells H. polygyrus infection→
transcription factor balance
Gut function unknown; ↓
delayed-type
hypersensitivity ↓ allergic
airway inflammation
(13)
Th17/Th1 Th17/Th1 hybrid
cells
RORγt+ Tbet+ IL-17+ IFNγ+
CD161+ (only in humans)
β7+ CCR6+
Naive T cells Cytokine-induced upregulation
of Tbet
Associated with Crohn’s
disease
(14–21)
ex-Th17Th1 cells Tbet+ RORγt− IL-17− IFNγ+
β7+ CCR6+
Committed Th17 cells
Th17/Th2 Th17/Th2 RORγt+ GATA-3+ IL-4+
GM-CSF+ IL-17+
Not investigated CD4-dependent Bcl11b-knock
down or IL-4 treatment of EAE
mice
↓ EAE (by redirecting
lymphocytes to the gut)
(22)
Th17-to-Treg Co-expression of
Treg and Th17
markers not shown
Committed Th17 cells PPARγ activation that promotes
iTreg induction
↓T cell transferred colitis (23)
Treg-to-Th17 Treg/Th17 hybrid
cells
Foxp3+ RORγt+ IL-17+ β7+
CD103+ suppressive
Committed Treg cells Micro-environmental cues in
PPs of Crohn’s disease patients
↓ Crohn’s disease (24, 25)
Th17/Tfh ex-Th17Tfh RORγt− IL-17− Bcl-6+
CXCR5+ PD-1+ IL-21+
Committed Th17 cells Not IL-23 Required for IgA-producing B
cells
(26)
Treg/Tfh ex-TregTfh cells Foxp3− Bcl-6+, IL-21+,
CXCR5+, CD40L+, ICOS+,
PD-1+, and CD28+
Committed Treg cells Micro-environment of PPs.
Requirement for B cells and
CD40:CD40L interaction.
Involvement of IL-6 and
autocrine IL-21
Induced GC formation in PPs
and IgA-producing cells in
the gut
(27, 28)
CD4+/cytotoxic
CD4+ T cells
CD4+ CTLs CD4+ CD8αα+Runx3+
ThPOK− granzyme B+
CD4+ T cells Continuous antigenic
stimulation, IL-15,
non-pathogenic
microorganisms, TGFβ, RA
↓ Colitis (29, 30)
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expression many months after systemic infection with LCMV. Ear-
lier work from the same group has shown that the development
of LCMV-specific Th1/Th2 hybrid cells originating from antigen-
experienced Th2 cells required TCR engagement, not just a “Th1
milieu” provided by LCMV challenge and are stable in vivo for
months (35).
Functionally, the Th1/Th2 hybrid cells have the capacity to
elicit Th1 and Th2 cell responses but with a decreased Th-specific
potency compared their single identity counterpart. Mice that
received in vitro derived Th1/Th2 cells before the induction of
type-1 inflammation showed signs for delayed-type hypersensitiv-
ity but not as strong as after a transfer of pure Th1 cells. Similarly,
the transfer of Th1/Th2 cells reduced the signs for induced allergic
airway inflammation compared to a Th2 cell transfer (13).
Th17/Th1 CELL PLASTICITY
In health, Th17 cells preferentially home to small intestinal LP
(26) and are important for intestinal homeostasis [reviewed in Ref.
(36)]. Th17 cells are characterized by the expression of IL-17A, IL-
17F,and IL-22 and the lineage-defining transcription factor RORγt
(37–39), which acts in co-operation with other transcription fac-
tors, including aryl hydrocarbon receptor (AhR) and RORα (40,
41). Shortly after the first descriptions of Th17 cells, cells making
both IL-17 and IFNγ, so called double producers, were noted. In
the intestine of patients with Crohn’s disease (CD), IL-17A IFNγ-
double positive CD4+ T cells co-expressing RORγt and Tbet have
been found (14), sometimes with frequencies above those of single
positive T cells (15). Cosmi et al. characterized these double pro-
ducers further and found that virtually all IL-17+IFNγ+CD4+
T cells, as well as Th17 cells expressed the lectin-like surface
molecule CD161 (15). This led them to conclude that human
Th17 and Th17/Th1 cells exclusively originate from an NKT-like
CD161+CD4+ T cell precursor. Furthermore, Kleinschek et al.
showed that CD161+CD4+ T cells preferentially home to the gut
due to their high expression levels of CCR6 and integrin β7. They
confirmed that these cells can be induced to produce IFNγ in
addition to IL-17 (16). In mice, colitis studies revealed not only
the presence of Th1/Th17 hybrid cells (17–19) but also that Th17
cells, initially unable to produce IFNγ, abolish IL-17 production
completely and switch on IFNγ (ex-Th17Th1) (18, 20, 42).
Hirota et al. used an IL-17-fate reporter mouse that perma-
nently marks IL-17-producing cells to show that these ex-Th17Th1
cells undergo a near complete switch from Th17 cell to Th1 cell,
except for the maintenance of IL-1R and AhR expression as rem-
nants of their former identity (26). Since Th1 cells are not known
for the expression of the IL-1R, ex-Th17Th1 cells are unique within
the Th1 lineage in the ability to respond to the acute phase reactant
IL-1. AhR expression has been shown to increase Th17 cell activity
and particularly drive the expression of IL-22 (40). It is currently
not known what the role of AhR is in ex-Th17Th1 cells, however,
it is tempting to speculate that there is a role in coordinating IL-
22 production at barrier sites such as the intestine, where IL-22R
is expressed by epithelial cells (43). IL-22 deficiency worsens the
colitis induced by either dextran sodium sulfate or by T cell trans-
fer (44), and results in reduced secretion of antimicrobial agents
important for maintaining epithelial health (45, 46). Interestingly,
AhR has been shown essential for the long-term maintenance of
lymphoid cells, such as innate lymphoid cells (ILC) type 3, intra-
epithelial lymphocytes (IELs), and tissue resident cells, at epithelial
barrier sites (47–49). This suggests that ex-Th17Th1 cells may be
maintained in the intestine providing long-term protection or
upholding aberrant immunity, in part through IL-22 signaling,
with the help of AhR ligands.
Because the frequency and number of IL-17/IFNγ double pro-
ducers are increased in the gut of CD patients (14), they have been
implicated in disease pathogenesis. However, it is unknown if the
presence of Th17/Th1 hybrid cells in CD patients are a cause or
a consequence of the disease. These hybrid cells could develop
as a bystander product of inflammation, or might drive the ini-
tial inflammatory response. In colitis models, the pathogenicity of
Th1/Th17 hybrid cells and ex-Th17 cells is linked with Tbet. How-
ever, the role for Tbet in the pathogenicity of Th17 cells remains
controversial (50–53) and switching to Th17/Th1 or IFNγ+ex-
Th17 might involve Runx family members in co-operation with
Tbet (54).
Th17/Th2 CELL PLASTICITY
Naïve T cell activation in vitro in the presence of IL-4 inhibits
RORγt expression and IL-17 production (55), which makes the
existence of T cells with a hybrid phenotype of Th17/Th2 cells
seem unlikely. However, in vivo studies identified CD4+ T cells
simultaneously expressing IL-4 and IL-17 (22). These Th17/Th2
hybrid cells were reported to be present in draining LNs and
mLNs of mice with experimental autoimmune encephalomyelitis
(EAE) that either had a CD4-specific Bcl11b-deficency or were
treated with IL-4. In EAE, Th17 cells are pathogenic when they
gain access to the central nervous system (CNS), contributing to
CNS inflammation. EAE-induced Bcl11b-deficient mice showed a
delayed onset and reduced disease severity, attributed to a redi-
rection of T helper cells away from a draining LN/CNS route
to the intestine. Even though an accumulation of Th17 cells
in the intestine has been reported to cause colitis these mice
were asymptomatic.
Th17-TO-Treg CELL PLASTICITY
A different approach was chosen to address Th17 cell plasticity
by Carbo et al. (23). Computational modeling predicated a role
of the nuclear receptor peroxisome proliferator-activated receptor
gamma (PPARγ) in a phenotype switch from Th17-to-Treg cell
in the murine gut. In silico, PPARγ activation of fully differenti-
ated Th17 cells reduced IL-17 and RORγt, while initiating Foxp3
expression. In vitro, analysis confirmed these in silico predictions.
Polarized Th17 cells treated with pioglitazone, a synthetic PPARγ
agonist, induced Foxp3 and inhibited RORγt and IL-17A expres-
sion. This effect was not observed in PPARγ-deficient Th17 cells.
Mice that received pioglitazone orally to activate PPARγ recovered
from transferred colitis, with a phenotypic switch in transferred T
cells, from a predominantly Th17 phenotype to an iTreg cell phe-
notype characterized by decreased IL-17 and RORγt and increased
expression of Foxp3.
In humans, IL-17+ FOXP3+ T cells were identified in inflamed
intestinal mucosa of patients with CD, but not in patients with
ulcerative colitis or healthy controls (24). These Treg/Th17 cells
shared characteristics of Th17 and Treg cells, expressing RORC
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(encoding RORγt) and CD161 and showing Treg-typical suppres-
sor activity in vitro. In addition, the majority these FOXP3+IL-
17+ T cells expressed CCR6, a receptor that mediates homing to
skin and mucosal tissues (56) and high levels of integrin α4β7
and CD103, markers for gut-homing potential. Analysis of the
TCR repertoire suggested that FOXP3+IL-17+ cells develop from
FOXP3+ Tregs when exposed to inflammatory signals in the gut
(24) and in vitro stimulation of FOXP3+ circulating cells can result
in IL-17 expression (57). In human tonsils obtained after routine
tonsillectomy, up to 25% of the FOXP3+CD4+ T cell popula-
tion can produce IL-17 upon activation (25). These FOXP3+IL-17
producers are CCR6+, co-express RORC and FOXP3 and dis-
play cell-contact dependent suppressive properties (25). Whilst
FOXP3+IL-17+ cells in the LP appear unique to areas of intestinal
inflammation in CD (24), in tonsil they are much more readily
identifiable (25). Together these observations suggest that het-
erogeneity in the GALT micro-environment can influence Th17–
Treg plasticity. Intriguingly, the FOXP3+IL-17+ T cells from CD
patients also express IFNγ, IL-22, and IL-21 (24), suggesting plas-
ticity not just between Th17 and Treg, but with other CD4+
effector states.
Th17/Tfh CELL PLASTICITY
In addition to a Th17-to-Th1 conversion, Th17 cells can acquire
a Tfh cell phenotype (26), including expression of Bcl-6, the
transcription factor that is both necessary and sufficient for the
formation of Tfh (58–60). Tfh provide antigen-specific help to
germinal center (GC) B cells via CD40L, IL-4, and IL-21 (61). The
only GALT to contain GCs are the PP and mLNs, and within these
structures Tfh act to select high-affinity GC B cells to exit the PP
GC as long-lived IgA secreting plasma cells and memory B cells
(62). An IL-17-fate reporter mouse was used to show that trans-
fer of Th17 cells into a T cell deficient recipient could support
high-affinity IgA production in the GCs of PPs by converting into
Tfh cells (26). Interestingly, this conversion resulted in the loss
of IL-17 expression and other Th17 associated features to enable
these cells to effectively switch into Tfh cells in the PP. The phys-
iological relevance of these ex-Th17Tfh cells in host defense or in
microbial homeostasis remains to be elucidated. But, the essential
role for Th17 cells in the production of high-affinity IgA (26) sug-
gests that this Th17 to Tfh cell switch is critical for IgA-dependent
immune responses.
IgA production in the gut can occur outside the GC but the IgA
species are low-affinity, with little somatic hypermutation (63).
The production of GC-derived IgA is essential for the maintenance
of bacterial communities in the gut. Mice that express a mutated
form of activation-induced cytidine deaminase (AIDG23S) that
allows class switch to IgA but not somatic hypermutation have
alterations of the gut microbiota, suggesting that IgA derived from
the PP GC response is essential for maintaining homeostasis of
the gut microbiota (64). This demonstrates that high-affinity IgA
promotes healthy microbiota, rather than target it for elimination
like IgG derived from the LN and spleen (62). The production of
immunoglobulin that nourishes commensal microbiota is one of
the features that discriminates the function of GALT GCs from
peripheral GCs, and may be one of the reasons that GALT GC T
cells exhibit plasticity that is not observed in the GCs of lymph
nodes and spleen. Selective IgA deficiency (OMIM 137100) is a
common incidental finding amongst blood donors (with numer-
ous reports since the 1970s), without any particular symptomatol-
ogy originally appreciated [reviewed in Ref. (65)]. However, it has
recently been reported that IgA-deficient persons have increased
frequency of gastrointestinal and respiratory infections, and of
allergy and autoimmunity (66).
Treg-TO-Tfh CELL PLASTICITY
In mice, Th17 cells are not unique in their ability to switch to
a Tfh cell phenotype, also Foxp3+ cells have been reported to
be able to do this in the PP GCs (27, 28). The first study used
adoptive transfer of CD4+EGFP+ cells from spleen or LNs of
Foxp3–EGFP reporter mice into T cell deficient mice (27). Whilst
80% of Foxp3+ T cells switched off Foxp3 expression in the PPs,
about half of the transferred cells kept their Foxp3+ profile in the
LP of the small intestine as well as in the spleen. The ex-TregTfh
cells that form in the PP expressed Bcl-6 and also IL-21, CXCR5,
CD40L, ICOS, PD-1, and CD28, all associated with Tfh cell func-
tion (61). Functionally, it has been shown that these ex-TregTfh cells
induce GC formation in PPs and facilitate IgA-producing cells in
the gut (27). These findings appear in contrast with the work of
Hirota et al. that identified ex-Th17Tfh cells (26). In the study by
Hirota et al., mucosal Foxp3+ T cells transferred into TCRα−/−
hosts did not differentiate into Tfh cells, induce GC B cells or IgA
production. It remains unclear whether differences in the models
(Tsuji: CD3ε−/− recipients; Hirota: TCRα−/− recipients) or source
of cells transferred (Tsuji: spleen and LN, Hirota: mucosal origin)
or intestinal environment of the transfer recipients explain the dis-
crepancies. In a separate study, Takahashi et al. transferred iTreg
cells into TCRα−/−mice and showed that these cells can lose Foxp3
expression and become Tfh in the PP (67). Intriguingly, transferred
iTreg cells were more likely to lose Foxp3 expression in the PP
than in the spleen, suggesting that the micro-environment of the
gut affects the plasticity of Tregs. The conversion of Treg-to-Tfh
in the gut is controlled, in part, by expression of microRNA-10a
that suppresses Bcl-6 and Ncor2, thereby repressing of Treg-to-Tfh
conversion in the gut (67).
Not all Tregs within the PP convert into Tfh, however, there is
a regulatory population of CD4+ T cells in GCs; T follicular reg-
ulatory cells (Tfr) (68–70). Tfr are the progeny of Foxp3+CD4+
cells that share phenotypic characteristics of Tfh cells, including
CXCR5, PD-1, and Bcl-6 expression. In peripheral secondary lym-
phoid organs, Tfr control the size and output of the GC response
(68–70). In PP GCs, Tfr control the quality of IgA produced, which
in turn promotes diversity within the microbial community of the
gut (28). Taken together, conversion of Treg-to-Tfh in the gut is
finely balanced to ensure the ratio of Tfh to Tfr within the PP sup-
ports high-affinity IgA production and homeostasis of commensal
bacteria.
Th2-TO-Tfh CELL PLASTICITY
The gastrointestinal helminth parasite H. polygyrus has been
shown to give raise to Th1/Th2 hybrid cells but also been suggested
give rise to Th2/Tfh hybrid cells (71). These hybrids were described
as IL-4 producing CD4+ cells expressing CXCR5, ICOS and PD-
1, Bcl-6 and IL-21 and that localized in B cell follicles of mLNs
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after H. polygyrus infection. Zaretsky et al. found similar IL-
4+CXCR5+PD-1+ Th cells after immunization with schistoso-
miasis soluble egg antigen (72). A later study using dual reporters
for IL-4 and IL-13 and N. brasiliensis infection demonstrated that
Tfh phenotype cells express IL-4 but not IL-13, whereas Th2 cells
express both prototypic Th2 cytokines. Importantly, IL-4+ Tfh
cells are Bcl-6+ and do not express high levels of GATA-3, suggest-
ing that these cells are Tfh cells that produce IL-4 rather than bona
fide Th2/Tfh hybrids (73).
CD4+ T CELL INTO CYTOTOXIC CD4+ T CELL CONVERSION
Among the CD4+ IELs a population of cells has been described
that lost its CD4-lineage transcription factor ThPOK and acquired
the CD8-lineage transcription factor Runx3 (29, 30). The induc-
tion of Runx3 expression by CD4+ T cells was associated with
expression of CD8αα, the natural killer cell – and CTL-related
molecule 2B4 (CD244) and Tbet (29). In addition, these cells
expressed granzyme and the activation-induced degranulation
marker CD107a (LAMP-1) (30). As well as closely resembling
mature CD8+ CTLs, these cells showed high cytolytic activity.
At the same time, these cells lose their ability to produce IL-17 and
to express RORγt (29, 30). Fate-mapping and adoptive transfer
experiments by Mucida et al. showed that CD4+ CTLs originate
from ThPOK+ naive CD4+ T cells (30).
The loss of ThPOK together with the inability to produce IL-17
in the intestine had physiological implications on the develop-
ment of colitis. Conditional deletion of ThPOK in CD4+ T cells
prior to their transfer into lymphopenic Rag−/− deficient mice
enhanced the differentiation of CD4+CD8α+ CTLs in the gut of
the recipients, which, as a consequence, saw a reduction in intesti-
nal inflammation compared with controls (29). By contrast, the
transfer of Runx3-deficient CD4+ T cells resulted in an exacer-
bated intestinal inflammation, but provided recipient mice with
increased protection against infection with the enteropathogenic
bacterium Citrobacter rodentium (29). A role of CD4+ CTL cells
in celiac disease is suggested by their restriction to MHC class II,
their induction by dietary antigen, responsiveness to IL-15, and
cytotoxic potential (30).
MECHANISMS OF CD4+ T CELL PLASTICITY
Very little is known about the underlying mechanisms determin-
ing CD4+ T cell plasticity. It is likely that the same factors that
are involved in T cell differentiation are implicated in a phenotype
switch, but this remains largely untested.
The development of some CD4+ T hybrid cells or ex-Th lineage
cells seem to predominantly take place in the intestine, indicating
that the micro-environment has a major influence on CD4+ T cell
plasticity and identity. For example, the micro-environmental cues
contributing to a phenotype switch between Th17 and Tfh seem
to be unique to the PP, as the plasticity of Th17 cells toward a Tfh
cell fate was restricted to the micro-environment of PPs and did
not occur in peripheral LNs (26). Likewise, transferred Foxp3+
T cells lost Foxp3 expression and acquired Tfh features preferen-
tially in the PPs (27, 65). Further evidence of the unique nature
of the PP comes from in vitro stimulation assays in which APCs
from PP and spleen generate different CD4+ effectors (74, 75).
FIGURE 2 | Possible mechanisms of CD4+ T cell plasticity in the gut.
Factors enabling CD4+ T cell plasticity could, in part, originate
from the microbiota or dietary products that effect CD4+ T cells
either directly or indirectly via innate immune cells. These extrin-
sic cues can alter transcription factor and microRNA expression
and epigenetic markers such as histone modifications (Figure 2).
For example, microRNA-10a dampens the conversion of Treg cells
to both Th17 and Tfh cell fates (67). In addition, the cellular com-
position of the GALT, enriched in non-conventional lymphocytes
such as ILCs, IEL populations of TCRγδ+, and CD8αα+TCRαβ+ T
cells and mucosal associated innate NKT cells, is substantially dif-
ferent compared with other secondary lymphoid organs and will
contribute to a different environment in which T cells encounter
antigen and are maintained.
MICROBIOTA
The nature of antigen or metabolic products provided by the gut
microbiota plays a role in T cell plasticity. There are a num-
ber of examples where CD4+ T cell subsets are expanded in
response to particular microbial species and their products. Using
germ-free mice, a mixture of 17 Clostridia species were selected
from human gut flora for their ability to induce mucosal Tregs
(76). Introduction of these 17 strains mitigated colitis and aller-
gic diarrhea models (76). This protective effect is mediated by
short chain fatty acids, products of these 17 bacteria (and of Bac-
teroides fragilis, also shown to induce Tregs) (77). The microbiome
is shaped, in part by induced Tregs, and mice lacking induced
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Tregs are more susceptible to colitis and asthma (78). Thus
the gut microbiome is implicated in the protection of autoim-
munity and autoinflammation both in the gut and at distant
sites. Recent work provides evidence for a symbiosis between
CD4+ T cell subsets and the microbiome (28). Lack of Tfr
resulted in poor quality IgA production and a limited biodiver-
sity of the microbiome. The presence of Tfr permitted a more
diverse microbiome including a larger representation of non-
pathogenic Clostridia (28), which establishes a positive feedback
loop between CD4+ cells and the microbiome mediated through
SCFA, Foxp3 expression, and IgA production. This narrowing
of the microbiome and subsequently SCFA deplete environment
might explain the association between IgA deficiency and allergy
and autoimmunity (66). Taken together, these studies provide evi-
dence that the gut microbiota and CD4+ T cell fate within the
gut are inter-dependent, with each affecting the composition of
the other.
CD4+CD8α+ CTLs are absent from the intestines of germ-free
mice and of mice mono-colonized with segmented filamentous
bacteria (SFB), but appear in the intestines following reconsti-
tution with specific non-pathogenic microorganisms (30). Little
is known about the mechanisms how antigens originating from
microbiota induce a phenotype switch. However, data on Th17
cell differentiation indicate that SFB colonization promotes Th17
cell commitment by the expression of inflammation-associated
genes, such as the gene for serum amyloid A (SAA) (79). Some
Th17 cells from murine gut have TCR specific for SFB-derived
antigen (80). In addition, it has been shown that ATP derived
from commensal bacteria activates CD70high CD11clow cells in the
LP, leading to enhanced differentiation of Th17 cells (81). There-
fore, changes in the concentration of SAA or ATP could either
induce a switch toward Th17 phenotype or destabilize Th17 cell
commitment toward another phenotype.
DIETARY PRODUCTS
Dietary products, mainly after being processed by microorgan-
isms, can induce phenotype switch. PPARγ has been identified
to induce a Th17-to-Treg cell switch (23). This nuclear receptor
regulates fatty acid storage and glucose metabolism. Therefore,
consumption of food containing certain fatty acids may pro-
mote a phenotype switch from Th17-to-Treg cells. Several dietary
products have been reported to promote or inhibit lineage com-
mitment [reviewed in Ref. (2)]. It is likely that these factors are
also candidates to induce a phenotype switch of CD4+ T cells.
In addition, dietary products could influence a phenotype switch
by affecting metabolic and signaling pathways and epigenetic
status.
INNATE IMMUNE CELLS: PROVIDERS OF COSTIMULATION AND
CYTOKINES
Innate immune cells are abundant in the GALT. They have the
potential to influence CD4+ T cell plasticity via their determi-
nation of the micro-environment via the secretion of soluble
mediators, expression of co-stimulatory molecules, and via their
potential to act as APCs. Mucida et al. demonstrated that con-
tinuous activation of CD4+ T cells by oral administration of an
antigen is necessary for a phenotype switch to CD4+ CTLs (30). It
has been reported previously that antigen dose and peptide/TCR
affinity can influence Th commitment (82).
Co-stimulatory factors have been shown to play a role in Treg-
to-Tfh plasticity. Blocking the interaction of CD40, expressed on
APCs such as B cells and DCs, with CD40L, found on T cells, is
able to prevent a phenotype switch from Treg cell to Tfh cell (27).
The role of cytokines in Th17 cell plasticity has been studied by
several investigators but has not yet been fully elucidated. However,
it is clear that IL-23-dependent pathway does play an important
role. In Helicobacter hepaticus-induced typhlocolitis, mRNA levels
for IL-23p19 were elevated after bacterial inoculation and ex vivo
IL-17A+ cells isolated from the colitic intestine expressed both
subunits of the IL-23R, indicating that IL-23 acts on Th17 cells
to induce a program resulting in IFNγ production (18). T cell
transfer studies also showed that IL-23 is required for the appear-
ance of IL-17A+IFNγ+ double-producing T cells in the intestine.
Transferred naive CD4+ T cells developed to Th1/Th17 hybrid
cells in Rag−/− mice, but not in p19−/− RAG−/− mice [lacking
IL-23; (21)]. These studies were extended by Ahern et al. demon-
strating that in the intestine the emergence of IL-17A+IFNγ+
double-producing Th cells, but not IL-17A single producing Th
cells, requires T cell-intrinsic IL-23 signaling by transferring IL-
23R−/−CD45RBhigh CD4+ T cells into full hosts (17). In humans,
CD161+CD4+ T cells from CD patients readily produce IL-17 and
IFNγ upon stimulation with IL-23, whereas, in healthy subjects,
IL-1β was required alongside IL-23 (16).
The role of IL-12, the primary cytokine inducing Th1 cell dif-
ferentiation, in mediating Th17-to-Th1 cell conversion remains
controversial. In vitro, obtained results differ from those data being
observed in in vivo models. Upon transfer of naive CD4+ T cells,
Th17/Th1 cells were detected in the mLNs of IL12p35-Rag-double
deficient mice (lacking IL-12), demonstrating that IL-12 is negli-
gible in Th1/Th17 induction in the intestine (21). In contrast, Lee
et al. showed in vitro that in both IL-23 and IL-12 are able to
switch off IL-17 and enhance IFNγ production in a STAT4- and
Tbet-dependent manner. It has also been shown that ex vivo Th17
cells can be converted into a Th1-like phenotype following IFNγ-
induced expression of Tbet and acquisition of IL-12Rβ2 surface
expression (83, 84). Lee et al. investigated the effect of additional
cytokines on Th17 cell plasticity and found that Th17 cells require
TGFβ for sustained expression of IL-17F and IL-17A (20).
Although the precise role of IL-23 in the Th17-to-Th1 cell con-
version requires further investigation, it does not seem to play an
essential role in a phenotype switch from Th17 to Tfh cell. Th17
cells can give rise to Tfh cells in IL-23-competent and -deficient
mice (26). For a phenotype switch from Tregs to Tfh cells it has
been shown that the cytokine IL-6 can to down-regulate Foxp3,
and this may be relevant to Treg plasticity in the IL-6 rich PPs (85).
TRANSCRIPTION FACTORS
Transcription factors maintain and instruct lineage programs by
complex mechanisms, often involving several cooperating tran-
scription factors, and their binding and access to specific DNA
sequences. The expression of lineage determining transcription
factors is induced by multiple factors in the micro-environment,
including cytokines. Their regulation falls outside the scope of this
review, but their interactions are of importance in maintaining Th
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identity and are likely to play a prominent role in ultimately gener-
ating hybrid Th cells and Th identity conversions. Co-expression
of IFNγ and Th2-associated cytokines in the same T cell seems to
be enabled by signals that keep both Tbet and GATA-3 expression
in balance, which is in contrast to studies examining chromatin
modification at Tbx21 and Gata3 (86, 87).
The loss of a single transcription factor can tip the balance in
favor of an alternative lineage. In Bcl11b-deficient mice, GATA-3
expression in Th17 cells is unrestrained, resulting in GATA-3-
mediated IL-4 production (22). This change in cell phenotype
feeds back to the micro-environment, and has further implica-
tions for T cell biology. For example, the cytokine mix produced by
Th2/Th17 hybrid cells triggers gut-imprinting properties in DCs.
IL-4 together with GM-CSF enhance the expression of the enzyme
RALDH2 in DCs (88, 89), leading to elevated levels of RA (90) that
imprint gut-homing properties on T cells, such as α4β7 and CCR9
(91). Similarly, the termination of ThPOK in mature CD4+ T cells
enables the de-repression of the CTL program (30), resulting in
MHC class II restricted CD4+ T cells with a cytotoxic effector
function. This process can be further promoted by Runx3 (29).
The factors responsible for carefully balancing two transcrip-
tional programs within a single T cell may be present together
from the moment of T cell differentiation or may be induced later.
In vitro, data have shown that expression of one differentiation
program is often found to be mutually exclusive with factors from
another (55). Yet, differentiation of some programs are character-
ized by co-expression of two pathways from the start, such as seen
with iTreg differentiation in which T cells co-express Foxp3 and
RORγt from the start (25). These in vitro observations are often
not recapitulated in vivo and vice versa. This highlights missing
links in our understanding of which factors are required to deter-
mine full Th effector cell differentiation, which factors enable T
cells to postpone the identity decision, as well as those that can still
interfere at later stages.
EPIGENETICS
The observed stability or plasticity of Th subsets is governed by the
epigenetic regulation of the key transcription factors and cytokines
and their access to downstream genes (92). Whether a particular
gene is poised for expression is controlled by the chromatin struc-
ture and histone or DNA modification state. Wei et al. evaluated the
histone H3 methylation status over the entire genome in a variety
of defined Th subsets (87). Promoter regions for Tbx21 (encoding
Tbet) in Th1 cells and Rorc (encoding RORγt) in Th17 cells dis-
played a permissive methylation state (H3K4me3) associated with
full expression of these master regulators in each lineage. How-
ever, the promoter region for Tbx21 in Th17 cells had a bivalent
status characterized by H3K4me3/H3K27me3, reflecting the rela-
tive instability of these cells and their potential to acquire another
Th cell phenotype. In addition, it has been shown that treatment
of naïve T cells under Treg polarizing conditions with the fatty
acid, butyrate, enhances permissive acetylation in the promoter
region of the Foxp3 locus. Butyrate, being a large bowel fermenta-
tion product, provides a link between microbial products and Treg
cells by epigenetic mechanisms. Beyond histone modifications,
miRNAs offer a further tuning of gene expression and CD4+
phenotype, as illustrated earlier.
FUNCTION
CD4+ T cell plasticity is important in the resolution of infec-
tions but can contribute to immunopathogenesis. The ability to
switch or combine effector phenotypes can generally be seen as a
very useful feature in the arsenal of the adaptive immune system.
It is an additional tool providing flexibility to adequately con-
trol rapidly changing microorganisms. It allows the retention of
TCRs with a useful track record while displaying a high degree of
flexibility and adaptation depending on local environmental cues.
Therefore, a phenotype switch may facilitate the ability to respond
more quickly to changing immunological challenges and to suc-
cessfully terminate immune responses after pathogen clearance.
This flexibility may be especially important and useful at epithe-
lial interfaces, where luminal content is constantly changing and
the largest population of microorganism is encountered.
The ability to switch from one phenotype to another or obtain
features from two effector programs increases the efficiency of a
response. Combining effector mechanisms would enable the con-
trol of complex organisms that have evolved ways to deal with one
predominant effector subset. This implies that effector programs
can co-exists within one T cell, while the co-existences of differ-
ent effector subset within the same micro-environment may be
harder to achieve and maintain. It is worth noting that reports on
Th cells displaying a hybrid phenotype highlight that such cells
are less effective in dealing with situations where one part of their
identity is required compared with the single identity T cells. This
indicates that each identity is weakened by the presence of the tran-
scriptional program of the other, a feature that could be abused by
microorganisms. Conversely, producing these “weakened” T cells
may be method of peripheral tolerance – in an inflamed milieu,
T cells are stimulated under polarizing conditions and develop
a single identity, whereas non-inflamed milieu offers conditions
less favorable to any single identity and the “weakened” T cells are
tolerized.
An additional physiological role for CD4+ T cell plasticity is
the gaining of specific functional features that require aspects of
the previous full identity combined with a very specific trade. This
is the case for Tfh cells that can develop from committed Th17 or
Treg cells. In case of ex-Th17Tfh cells, they represent a subset of Tfh
cells that are specialized to promote high-affinity IgA production
in the GCs of PPs. A similar specialized role in GC B cell support
is likely the case for ex-TregTfh. These Tfh adopters have only been
found in the PP and only support IgA production, demonstrating
that this plasticity is unique to the gut environment.
Lastly, the transcriptional programs of each T cell effector sub-
set may not be compatible with long-term survival. Effector cells
that switch to a Th1 cell phenotype, may be maintained better as
memory cells due to the activity mediated by Tbet. Recent reports
describe a role of Tbet expression gradient as a regulator of CD4+
T cell memory formation, with highly Th1-polarized Tbet+ cells
displaying end-effector features and a short lifespan, whereas Th
cells with a lower expression of Tbet are able to enter the long-lived
memory T cell pool (93, 94). This is to some degree mimicked by
the finding that long-lived ex-Th17 cells acquired Tbet expression,
albeit at levels lower than their Th1 counterparts.
From a therapeutic viewpoint, contemplating a deliberately
induced phenotype switch could be used to up- or down-regulate
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the different effector arms of the adaptive immune response.
Dampening CD4+ T cell function would be useful for autoim-
mune disorders including CD and multiple sclerosis. In a coli-
tis model, oral pioglitazone induces a switch from Th17 to an
iTreg phenotype, improving disease and in EAE (a model of MS)
pathogenic Th17 cells can be redirected to gut, again improving
disease. Enhanced CD4+ T cell responses could improve cancer
surveillance and clearance. Whilst phenotypic switching appears
to occur in very specific circumstances, some of these conditions
are encountered spontaneously in healthy animals. Thus strate-
gies to induce phenotype switching, with minimal side effects or
co-morbidities, might be identifiable.
CONCLUSION
The nuanced view of Th differentiation suggested that within any
CD4+ effector population there are varying ratios of lineage deter-
mining transcription factors in each cell, with correspondingly
graded cellular phenotypes. In GALT these ratios integrate a num-
ber of different signals – microbial products, dietary influences,
costimulation, cytokines, and epigenetic modifications. Variation
in these signals and their interpretation is the substrate for hetero-
geneity of CD4+ T cells. As these microbial and dietary cues are
unique to GALT, perhaps even unique to the most luminal GALT,
such as PP, they could together provide a micro-environment per-
missive for plasticity, in contrast to other secondary lymphoid
organs, where plasticity is less frequently reported and where much
of the rigid in vivo definitions of the CD4+ subsets were derived.
Whether the phenotypic switches described herein are unique to
an in entero environment is unknown. It is possible that similar
blurring of CD4+ subsets occurs at other mucosal sites, balanc-
ing tolerance, protection, and immunopathology with the need to
maintain a diverse microbiome. To understand the precise factors
underlying plasticity is relevant for our understanding of host (and
microbiomial) health, host defense, pathogenesis of various gas-
trointestinal diseases and also for development and optimization
of vaccines, where an enforced Tfh phenotype is desired.
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